🔎 Trials Near Me

Hjem › Alvorlig depressiv lidelse › Ohio › Cincinnati

Alvorlig depressiv lidelse kliniske forsøg i Cincinnati, OH

11 studier for Alvorlig depressiv lidelse søger deltagere på steder i og omkring Cincinnati (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

RekruttererFase 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RekruttererFase 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT06559306

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

RekruttererFase 3
  • University of Cincinnati Medical Center, Cincinnati
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT05850689

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

RekruttererFase 3
  • University of Cincinnati, Cincinnati
Alder 12 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT07227454

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

RekruttererFase 3
  • Vanda Investigational Site, Cincinnati
Alder 18 til 65 · Alle køn · Opdateret 24. sep. 2026 · NCT06830044

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Mason · 19 mi væk
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06911112

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

RekruttererFase 1/2
  • Lindner Center of Hope, Mason · 19 mi væk
Alder 18 til 60 · Alle køn · Opdateret 3. aug. 2026 · NCT06795451

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

RekruttererFase 3
  • Clinical Research Site, Cincinnati
  • Clinical Research Site, Cincinnati
Alder 18 til 65 · Alle køn · Opdateret 24. jul. 2026 · NCT07484217

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Rekrutterer
  • Cincinnati Childrens Hospital Medical Center, Cincinnati
Alder 14 til 18 · Alle køn · Opdateret 11. feb. 2026 · NCT07217444

Study of ALTO-300 in MDD

RekruttererFase 2
  • Site 202, Cincinnati
Alder 18 til 70 · Alle køn · Opdateret 24. jul. 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

RekruttererFase 4
  • Clinical Research Site, Cincinnati
Alder 18 til 65 · Alle køn · Opdateret 23. jan. 2025 · NCT06223880

Alvorlig depressiv lidelse forsøg i andre byer

Andre studier i Cincinnati

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.